InVivo Biosystems offers CRISPR genome-edited animal models including zebrafish and C. elegans, and in vivo analytical services for early-stage disease studies and drug discovery which enables in vivo insights into human biology. At InVivo Biosystems, our mission is to help our clients develop and deliver solutions that improve the quality and effectiveness of their research. Our scientists work one-on-one with our clients throughout the process to ensure success. We place a high priority on timely communication and the most efficient solutions to your problems.
We are an officially licensed CRISPR solutions provider.
Conduct pathogenicity assessment of variants in disease related genes.
Our standard process includes:
We are a zebrafish CRO that offers multiple gene-editing services using CRISPR and Tol2 methods. Our services can significantly reduce your experiment design time and can be tailored to different experimental requirements. We offer a variety of service packages including fast, affordable Injection Mix to the comprehensive Full Build service to accommodate your level of expertise and budget.
Choose from a variety of services packages to fit the needs and budget of your lab. Mutation via CRISPR Gene Editing, Tagging via CRISPR Gene Editing, Expression, Expression Validation, and Inject Express. Choices range from the fast, affordable Custom Injection Mix to the comprehensive Full Build service package, allowing you to customize the components you need to accomplish your gene editing goals.
Visit InVivo Biosystem's C elegans Transgenics to learn more about the pricing and process. - Design, construct, and deliver custom reagents or genetically edited C. elegans optimized to your specifications. - Collaborate on project design to ensure transparency in the genome editing process and guarantee that you receive the transgenic best suited for your experiments. - Choices of genome editing methods are CRISPR, MosSCI and Extrachromosomal Array.
InVivo Biosystems has not received any reviews.
InVivo Biosystems has not received any endorsements.